People · Operator
Named in public records as an officer, director or promoter · active 2013–2013 · Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vigilant Biosciences, Inc. | — | Biotech / Pharma | Series B | $27.9M | $16.5M | 2013 |
Jeffrey H. J. Goodman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeffrey H. J. Goodman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan T. Lord | 1 | 5 |
| Eric Stone | 1 | 3 |
| Robert Hamilton | 1 | 2 |
| William Brodie | 1 | 2 |
| ROBERT T. HAMILTON | 1 | 2 |
| TIMOTHY C. BARABE | 1 | 2 |
| ERIC M. STONE | 1 | 2 |
| Timothy Barabe | 1 | 1 |
| Linda Niessen | 1 | 1 |
| LINDA C. NIESSEN | 1 | 1 |
| Stuart Heap | 1 | 1 |
| Eric H. J. Stone | 1 | 1 |
| Matthew H. J. Kim | 1 | 1 |
| Timothy H. J. Barabe | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.